Molecular analyses of the interactions between human NK receptors and their HLA ligands

M Valés-Gómez1, H Reyburn, J Strominger

  • 1Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA.

Human Immunology
|February 5, 2000
PubMed

Insights

Natural killer (NK) cell activity is controlled by receptor-ligand interactions. This review details how inhibitory and activating NK receptors bind to HLA ligands, influencing NK cell responses.

Area of Science:

  • Immunology
  • Cellular Biology
  • Molecular Biology

Background:

  • Natural killer (NK) cell cytotoxicity is a critical component of the innate immune system.
  • NK cell function is precisely regulated by a complex interplay of activating and inhibitory receptors on the NK cell surface.
  • The balance between signals from these receptors dictates whether an NK cell will attack a target cell.

Purpose of the Study:

  • To review the molecular mechanisms governing the interactions between NK cell receptors and their Human Leukocyte Antigen (HLA) ligands.
  • To elucidate the binding details of both inhibitory and activating NK cell receptors to their respective HLA targets.
  • To provide a comprehensive overview of the signaling pathways initiated by these receptor-ligand interactions.

Main Methods:

  • Literature review focusing on molecular interactions.
  • Analysis of structural and binding data for NK cell receptors and HLA molecules.
  • Synthesis of information on signaling pathways triggered by receptor engagement.

Main Results:

  • Detailed molecular interactions of killer cell immunoglobulin-like receptors (KIRs) with classical HLA class I molecules are described.
  • The binding of CD94/NKG2-A heterodimers to the non-classical HLA-E molecule is elucidated.
  • Activating NK cell receptor-ligand interactions are presented alongside their inhibitory counterparts.

Conclusions:

  • The precise molecular recognition between NK receptors and HLA ligands is fundamental to immune surveillance.
  • Understanding these interactions is key to deciphering NK cell-mediated immunity and developing immunotherapies.
  • The balance of activating and inhibitory signals, mediated by these receptor-ligand pairs, determines NK cell effector functions.